Technology
Why choose Mera?
Applications
Immunotherapy
Case Studies
Company
About Us
News
Resources
Contact Us
Technology
Why choose Mera?
Applications
Company
Contact Us
Applications
Immunotherapy
Case Studies
Company
About Us
News
Resources
Article
Blinatumomab shows increased T cell cytotoxicity in Mera – a 3D flow based model
June, 2026